Astrocyte elevated gene-1 overexpression in human primary gallbladder carcinomas: An unfavorable and independent prognostic factor

Oncology Reports

Volumn 26, Issue 5, 2011, Pages 1133-1142

  Sun, Wei ^a   Fan, Yue Zu ^a   Xi, Hao ^b   Lu, Xing Sui ^a   Ye, Chun ^a   Zhang, Jing Tao ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Astrocyte elevated gene 1; Gallbladder neoplasm; Prognosis

Indexed keywords

KI 67 ANTIGEN; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; ASTROCYTE ELEVATED GENE 1; CANCER INFILTRATION; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GALLBLADDER CARCINOMA; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; ONCOGENE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL ADHESION MOLECULES; FEMALE; GALLBLADDER NEOPLASMS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 80053135079     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1387     Document Type: Article

References (39)

1. Miller G and Jarnagin WR: Gallbladder carcinoma. Eur J Surg Oncol 34: 306-312, 2008. (Pubitemid 351312864)
2. Hsing AW, Gao YT, Devesa SS, Jin F and Fraumeni JF Jr: Rising incidence of biliary tract cancers in Shanghai, China. Int J Cancer 75: 368-370, 1998. (Pubitemid 28100037)
3. Malka D, Boige V, Dromain C, Debaere T, Pocard M and Ducreux M: Biliary tract neoplasms: update 2003. Curr Opin Oncol 16: 364-371, 2004. (Pubitemid 38870043)
4. Zhu AX, Hong TS, Hezel AF and Kooby DA: Current management of gallbladder carcinoma. Oncologist 15: 168-181, 2010.
5. Misra S, Chaturvedi A, Misra NC and Sharma ID: Carcinoma of the gallbladder. Lancet Oncol 4: 167-176, 2003. (Pubitemid 36322307)
6. Brown DM and Ruoslahti E: Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 5: 365-374, 2004. (Pubitemid 38482072)
7. Emdad L, Sarkar D, Su ZZ, et al: Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther 114: 155-170, 2007. (Pubitemid 46561534)
8. Lee SG, Su ZZ, Emdad L, Sarkar D and Fisher PB: Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci USA 103: 17390-17395, 2006. (Pubitemid 44788979)
9. Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ and Fisher PB: Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 353: 8-15, 2005. (Pubitemid 40805356)
10. Su ZZ, Kang DC, Chen YM, et al: Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 21: 3592-3602, 2002.
11. Hu G, Chong R, Yang Q, et al: MTDH Activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 15: 9-20, 2009.
12. Emdad L, Sarkar D, Lee SG, et al: Astrocyte elevated gene-1: a novel target for human glioma therapy. Mol Cancer Ther 9: 79-88, 2010.
13. Kikuno N, Shiina H, Urakami S, et al: Knockdown of astrocyte elevated gene-1 inhibits prostate cancer progression through up-regulation of FOXO3a activity. Oncogene 26: 7647-7655, 2007. (Pubitemid 350224215)
14. Liu H, Song X, Liu C, Xie L, Wei L and Sun R: Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells. J Exp Clin Cancer Res 28: 1-9, 2009.
15. Emdad L, Sarkar D, Su ZZ, et al: Activation of the nuclear factor kappa B pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res 66: 1509-1516, 2006. (Pubitemid 43259932)
16. Yoo BK, Emdad L, Su Z, et al: Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 119: 465-477, 2009.
17. Yu CP, Chen K, Zheng HQ, et al: Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 30: 894-901, 2009.
18. Li J, Zhang N, Song LB, et al: Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 14: 3319-3326, 2008.
19. Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF and Fisher PB: Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 27: 1114-1121, 2008. (Pubitemid 351253177)
20. Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ and Fisher PB: Molecular basis of nuclear factor-kappa B activation by astrocyte elevated gene-1. Cancer Res 68: 1478-1484, 2008. (Pubitemid 351346856)
21. Khuda IIE, Koide N, Noman ASM, et al: Astrocyte elevated gene-1 (AEG-1) is induced by lipopolysaccharide as toll-like receptor 4 (TLR4) ligand and regulates TLR4 signalling. Immunology 128: e700-e706, 2009.
22. Hu GH, Wei Y and Kang YB: The multifaceted role of MTDH/AEG-1 in cancer progression. Clin Cancer Res 15: 5615-5620, 2009.
23. Emdad L, Lee SG, Su ZZ, et al: Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc Natl Acad Sci USA 106: 21300-21305, 2009.
24. Song H, Li C, Li R and Geng J: Prognostic significance of AEG-1 expression in colorectal carcinoma. Int J Colorectal Dis 25: 1201-1209, 2010.
25. Song H, Li C, Lu B, Zhang A and Geng S: Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer. Int J Gynecol Cancer 20: 1188-1196, 2010.
26. Yoo BK, Gredler R, Vozhilla N, et al: Identification of genes conferring resistance to 5-fluorouracil. Proc Natl Acad Sci USA 106: 12938-12943, 2009.
27. Chen Y, Jiang L, She F, et al: Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism. Mol Cell Biochem 345: 77-89, 2010.
28. Zong H, Yin B, Chen J, Ma B, Cai D and He X: Over-expression of c-FLIP confers the resistance to TRAIL-induced apoptosis on gallbladder carcinoma. Tohoku J Exp Med 217: 203-208, 2009.
29. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
30. Liu L, Wu J, Ying Z, et al: Astrocyte elevated gene-1 up-regulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res 70: 3750-3759, 2010.
31. Song L, Li W, Zhang H, et al: Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. J Pathol 219: 317-326, 2009.
32. Lee SG, Jeon HY, Su ZZ, et al: Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene 28: 2476-2484, 2009.
33. Li J, Yang L, Song L, et al: Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene 28: 3188-3196, 2009.
34. Falkson G, Macintyre JM and Moertel CG: Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile-duct cancer. Cancer 54: 965-969, 1984. (Pubitemid 14069807)
35. Ducreux M, Rougier P, Fandi A, et al: Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol 9: 653-656, 1998. (Pubitemid 28318199)
36. Alberts SR, Al-Khatib H, Mahoney MR, et al: Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial. Cancer 103: 111-118, 2005. (Pubitemid 39665463)
37. Feisthammel J, Schoppmeyer K, Mossner J, Schulze M, Caca K and Wiedmann M: Irinotecan with 5-FU/FA in advanced biliary tract adenocarcinomas: a multicenter phase II trial. Am J Clin Oncol 30: 319-324, 2007. (Pubitemid 46884156)
38. Wagner AD, Buechner-Steudel P, Moehler M, et al: Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials. Br J Cancer 101: 1846-1852, 2009.
39. Yoo BK, Chen D, Su ZZ, et al: Molecular mechanism of chemoresistance by astrocyte elevated gene-1. Cancer Res 70: 3249-3258, 2010.